We partner with biotechnology companies developing cutting‑edge therapies, diagnostics, and technologies. Our linguists understand the scientific complexity and evolving terminology that define this sector, ensuring clarity and precision across all documentation.
Our expertise includes:
- Preclinical research documentation Study reports, assay descriptions, molecular biology content, and early‑stage discovery materials.
- Genomics and proteomics content Highly technical materials requiring deep familiarity with emerging scientific language.
- Cell and gene therapy documentation Protocols, manufacturing records, and regulatory submissions for ATMPs and other advanced therapies.
- CMC documentation Detailed chemistry, manufacturing, and controls content requiring strict accuracy and consistency.
- Regulatory submissions IND/IMPD modules, briefing packages, and responses to authority queries.
- Scientific publications and conference materials Manuscripts, posters, abstracts, and presentations for global audiences.
By supporting biotechnology organizations with scientifically rigorous and regulator‑ready translations, we help accelerate innovation and ensure that complex discoveries are communicated clearly across global teams, partners, and authorities. Our work enables biotech companies to advance breakthrough therapies, collaborate internationally, and move confidently through each stage of development.
medicaltranslations.gr 